SEP 14, 2016 11:18 AM PDT

Study Links RNA Alterations to Stomach Cancer

WRITTEN BY: Xuan Pham

DNA mutations that cause mutations get a lot of press. But problems with RNA and proteins can also lead to cancer. Shedding light on RNA and cancer, scientists at the Cancer Science Institute of Singapore have identified 2 proteins that influence RNA editing and is associated with gastric cancer. Their results also point out potential biomarkers for early detection of this disease.



Image credit: Pixabay.com


 
RNA (ribonucleic acid) is an intermediary molecule that allows the genetic code to be converted into proteins that are vital to all cells. Just as mutations can occur with the sequence of DNA, the process of converting DNA into RNA can also lead to mutations. Furthermore, RNA molecules are subject to a variety of modifications that also create opportunities for errors.
 
“Currently, most molecular studies on gastric cancer have focused on the alterations in DNA sequences,” said Lielei Chen, senior author of the study. “Despite recent discoveries that shed light on the cancer-causing role of RNA in cancer progression, the alterations in these RNA sequences and its contribution to the development of gastric cancer have not been well studied.”
 


 In probing this possible link between RNA changes and cancer, Chen and her team identified 2 proteins: ADAR1 and ADAR2. These are involved in modifying RNA after the genetic code has been transcribed. Interestingly, ADAR1 is a cancer-promoting gene, and ADAR2 is a cancer suppressor gene. The researchers think the balance between these two proteins can influence RNA editing and, ultimately, gastric cancer.
 
“Our team is the first to conduct a comprehensive analysis demonstrating that changes in RNA sequences, which are caused by the differentially expressed RNA editing enzymes ADAR1 and ADAR2 in gastric tumors, may serve as a novel driving force for gastric cancer," said Chen.
 
The team found that RNA editing seemed to vary with the degree of cancer progression. That is, more RNA editing was observed in cancerous lesions. Furthermore, they found that patients diagnosed with gastric cancer tended to have the biggest imbalance of ADAR 1/2 levels, suggesting these proteins play key roles in the progression of the cancer.
 


Beyond linking ADAR levels to gastric cancer, Chen’s team is excited about the prospects of turning this into diagnostic biomarkers, which could help to detect this disease earlier.
 
Gastric cancer, also known as stomach cancer, is the fifth most common cancer worldwide and the third most common cause of cancer-related deaths. About 1 in 111 people will develop stomach cancer in their lifetime, though the risks are higher for men. For 2016, the estimated incidence of new cases is over 37,000 for the U.S. alone. Due to late diagnoses, the outcome is poor with this cancer type and only about 25 percent of people survive past the five-year mark.

Additional source: National Library of Medicine, National University of Singapore

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 26, 2021
Cancer
COVID-19 Vaccination Induces Strong Immunity in Cancer Patients
AUG 26, 2021
COVID-19 Vaccination Induces Strong Immunity in Cancer Patients
Cancer patients have a higher risk of developing severe symptoms from a COVID-19 infection.   Many cancer pati ...
SEP 16, 2021
Cancer
Inspiring Hope during Childhood Cancer Awareness Month
SEP 16, 2021
Inspiring Hope during Childhood Cancer Awareness Month
Childhood cancers, also known as pediatric cancers, are diagnosed in patients up to 14 years old.  Estimates for 20 ...
SEP 15, 2021
Cell & Molecular Biology
The Molecular 'Anchors' That Hold Cells in Place
SEP 15, 2021
The Molecular 'Anchors' That Hold Cells in Place
Cells in the body are held in place with a kind of molecular anchor, called focal adhesions, where cells are linked to c ...
OCT 14, 2021
Immunology
'Bio-Betters' Form the Next Wave of Cancer Therapies
OCT 14, 2021
'Bio-Betters' Form the Next Wave of Cancer Therapies
  Antibodies are blood proteins with highly specialized functions: to recognize and eliminate bacteria, viruses, an ...
NOV 09, 2021
Immunology
Wikipedia, but Make It Immune Cells
NOV 09, 2021
Wikipedia, but Make It Immune Cells
Scientists have established the first searchable database of complex immune data, providing the foundations for a new er ...
DEC 09, 2021
Cancer
Inflammation: Naughty or Nice List?
DEC 09, 2021
Inflammation: Naughty or Nice List?
Aulus Cornelius Celsus, a Roman physician, first identified the four major characteristics of inflammation in the first ...
Loading Comments...